Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
13.38
-0.40 (-2.90%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $665.34 million as of October 31, 2024. Its market cap has increased by 73.99% in one year.
Market Cap
665.34M
Enterprise Value
374.12M
1-Year Change
73.99%
Ranking
Category
Stock Price
$13.38
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $665.34M, an increase of 6.47%. That is a compound annual growth rate of 3.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2024 | 685.20M | 93.83% |
| Dec 29, 2023 | 353.50M | -43.43% |
| Feb 10, 2023 | 624.91M | - |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oculis Holding AG | 707.02M |
| Standard BioTools | 703.34M |
| Lexicon Pharmaceuticals | 699.49M |
| AnaptysBio | 686.08M |
| Astria Therapeutics | 685.00M |
| Ironwood Pharmaceuticals | 679.69M |
| Opthea | 677.98M |
| ABIVAX Société Anonyme | 676.72M |